Cholangio Cancer
New Cholangio Cancer Research from Faculty of Science Described
Published in Gene Therapy Weekly, February 16th, 2012
2012 FEB 16 -- A new study, "Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival," is now available. According to the authors of a study from Bangkok, Thailand, "Cholangiocarcinoma is frequently found to invade local tissues and metastasize to distal organs. We investigated the expression of CD24 in cholangiocarcinoma samples and its prognostic significance."
"In addition, the cellular function of CD24 was studied in the RMCCA1 cholangiocarcinoma cell line. High CD24 expression significantly correlated with lymph node metastasis and positive surgical margins in cholangiocarcinoma patients....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-02-16)
More Articles from Gene Therapy Weekly
- HIV/AIDS
Viral Genetics Inc. Issues 2011 Year in Review and 2012 Outlook - Clinical Trial Research
U.S. Food And Drug Administration Approves Pfizer's INLYTA(R) axitinib For Patients With Previously Treated Advanced Renal Cell Carcinoma RCC - Biotechnology
Studies from University of Milan Yield New Data on Biotechnology - Serous Carcinoma
Studies from Laboratory of Cell Biology Further Understanding of Serous Carcinoma - Colon Cancer
Researchers from Graduate School of Medicine Describe Findings in Colon Cancer - Wilms' Tumor
Research on Wilms' Tumor Reported by Investigators at Osaka University - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
